Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | CPT2 | P23786 | 1/20 | 0.34 |
| ▸ | CPT1A | P50416 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CDC7 | O00311 | 1/20 | 0.33 |
| ▸ | USP7 | Q93009 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | F11 | P03951 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.33 |
| ▸ | WNT3A | P56704 | 1/20 | 0.33 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.33 |
| ▸ | CLK1 | P49759 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL925399 | 0.91 | TRPA1 (0.40) | FABP4TRPA1FFAR4CPT2CPT1A | |
| SCHEMBL923645 | 0.91 | TRPA1 (0.41) | FABP4TRPA1FFAR4CPT2CPT1A | |
| SCHEMBL922867 | 0.90 | USP7 (0.36) | FABP4TRPA1FFAR4CPT2CPT1A | |
| SCHEMBL922985 | 0.90 | ATR (0.38) | FABP4TRPA1FFAR4ROCK2 | |
| SCHEMBL923783 | 0.88 | PTGER1 (0.40) | TRPA1FFAR4CPT2CPT1ABRD4 | |
| SCHEMBL924514 | 0.86 | USP7 (0.38) | FABP4TRPA1CPT2CPT1AROCK2 | |
| SCHEMBL923766 | 0.86 | TRPA1 (0.39) | FABP4TRPA1FFAR4CPT2CPT1A | |
| SCHEMBL923774 | 0.85 | ABCB1 (0.42) | TRPA1CPT2CPT1AROCK2MAPK14 | |
| SCHEMBL923053 | 0.84 | TRPA1 (0.39) | FABP4TRPA1FFAR4CPT2CPT1A | |
| SCHEMBL923765 | 0.84 | AR (0.38) | TRPA1FFAR4BRD4CREBBPUSP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9006225-B2 | Stable pharmaceutical composition | ASAHI KASEI PHARMA CORPORATION (JP) | 2015-04-14 | — | — | US | disclosed |
| EP-2620431-A1 | Novel crystals of substituted phenylalkanoic acid and production process | Asahi Kasei Pharma Corporation (JP) | 2013-07-31 | — | — | EP | disclosed |
| EP-2045244-B1 | NOVEL CRYSTAL OF SUBSTITUTED PHENYLALKANOIC ACID AND PRODUCTION PROCESS | ASAHI KASEI PHARMA CORP (JP) | 2013-04-03 | — | — | EP | disclosed |
| US-7935720-B2 | Crystal of substituted phenylalkanoic acid ester and process for producing the same | ASAHI KASEI PHARMA CORPORATION (JP) | 2011-05-03 | — | — | US | disclosed |
| US-20110021593-A1 | NOVEL CRYSTAL OF SUBSTITUTED PHENYLALKANOIC ACID ESTER AND PROCESS FOR PRODUCING THE SAME | SHODA MOTOSHI | 2011-01-27 | — | — | US | disclosed |
| US-7838546-B2 | Crystal of substituted phenylalkanoic acid ester and process for producing the same | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| EP-2236135-A1 | STABLE PHARMACEUTICAL COMPOSITION | Asahi Kasei Pharma Corporation (JP) | 2010-10-06 | — | — | EP | disclosed |
| US-20100234440-A1 | NOVEL CRYSTAL OF SUBSTITUTED PHENYLALKANOIC ACID ESTER AND PROCESS FOR PRODUCING THE SAME | SHODA MOTOSHI | 2010-09-16 | — | — | US | disclosed |
| US-20100041725-A1 | STABLE PHARMACEUTICAL COMPOSITION | ASAHI KASEI PHARMA CORPORATION (JP) | 2010-02-18 | — | — | US | disclosed |
| US-7560478-B2 | Crystal forms of substituted phenylalkanoic acids and process for producing the same | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-07-14 | — | — | US | disclosed |
| EP-2045244-A1 | NOVEL CRYSTAL OF SUBSTITUTED PHENYLALKANOIC ACID AND PRODUCTION PROCESS | Asahi Kasei Pharma Corporation (JP) | 2009-04-08 | — | — | EP | disclosed |
| US-20080070967-A1 | Novel crystal forms of substituted phenylalkanoic acids and process for producing the same | ASAHI KASEI PHARMA CORPORATION (JP) | 2008-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041725-A1 | STABLE PHARMACEUTICAL COMPOSITION | SLC5A1, SLC5A2, SLC2A9 | FABP4 2375/4885TRPA1 2246/4885FFAR4 1679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.